You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 25, 2025

Drug Price Trends for ANTACID XTRA STRENGTH CHEW TAB


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for ANTACID XTRA STRENGTH CHEW TAB

Average Pharmacy Cost for ANTACID XTRA STRENGTH CHEW TAB

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
ANTACID XTRA STRENGTH CHEW TAB 24385-0106-80 0.03282 EACH 2025-03-19
ANTACID XTRA STRENGTH CHEW TAB 24385-0106-80 0.03250 EACH 2025-02-19
ANTACID XTRA STRENGTH CHEW TAB 24385-0106-80 0.03208 EACH 2025-01-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Global Antacids Market Analysis and Projections for Antacid Xtra Strength Chew Tabs

Introduction to the Antacids Market

The global antacids market is experiencing significant growth, driven by various factors including changing dietary habits, increasing prevalence of gastrointestinal disorders, and a shift towards self-care and over-the-counter (OTC) solutions. Here’s a comprehensive analysis of the market and its implications for products like Antacid Xtra Strength Chew Tabs.

Market Size and Growth Projections

As of 2023, the global antacids market was valued at approximately USD 7.2 billion and is projected to reach USD 10.9 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 4.8% from 2024 to 2032[1][4].

Key Drivers of the Antacids Market

Changing Dietary Preferences and Lifestyle

The increasing consumption of processed and fast foods, along with inconsistent eating and sleeping patterns, is leading to higher acidity levels in the population. This trend is expected to fuel market expansion in the coming years[1].

Prevalence of Gastroesophageal Reflux Disease (GERD)

GERD is a prevalent gastrointestinal illness affecting approximately 20% of individuals in Western countries. The incidence in the United States ranges from 18.1% to 27.8%, with men having a slightly higher rate. This high prevalence is a significant driver for the antacids market[1].

Convenience and Self-Care

Consumers are increasingly preferring OTC solutions for managing common digestive issues, driven by the desire for convenience and cost-effectiveness. Products like Antacid Xtra Strength Chew Tabs, which offer quick relief and come in flavorful options, are particularly popular[1][3].

Market Segmentation

By Drug Class

Proton Pump Inhibitors (PPIs) dominate the market due to their effectiveness in reducing stomach acid production. However, acid neutralizers, such as calcium carbonate, are also in high demand, especially in the form of chewable tablets[1].

By Formulation Type

The tablet segment, particularly chewable tablets, is expected to grow significantly. These tablets are convenient, provide precise dosing, and come in various flavors, enhancing patient adherence to medication[1][4].

By Distribution Channel

Retail pharmacies and online pharmacies are key distribution channels, with retail pharmacies expected to account for a significant portion of total sales. The ease of access and convenience offered by these channels are crucial for market growth[1][3].

Antacid Xtra Strength Chew Tabs: Market Analysis

Product Features

Antacid Xtra Strength Chew Tabs, such as those offered by Up&up, are formulated with 750mg of calcium carbonate, providing quick relief from heartburn, acid ingestion, and sour stomach. These tablets are chewable, come in mixed fruit flavors, and are designed for easy consumption[2].

Market Positioning

Given the preference for chewable and flavored tablets, Antacid Xtra Strength Chew Tabs are well-positioned in the market. The convenience and taste of these tablets align with consumer trends, making them a competitive product in the antacids market.

Price Projections

The pricing of antacids, including chewable tablets, is generally competitive and influenced by the brand, formulation, and distribution channel. As the market grows, prices are expected to remain relatively stable, with premium products potentially commanding higher prices due to their convenience and effectiveness.

Competitive Landscape

Major players in the antacids market include Sun Pharmaceuticals Ltd, Reckitt Benckiser Group plc, GlaxoSmithKline plc, and Pfizer Inc. These companies are investing in research and development to differentiate their products and cater to consumer preferences for convenient and effective antacid solutions[1].

Regional Market Analysis

North America

North America holds a dominant position in the antacids market, driven by high consumer awareness and the prevalence of gastrointestinal disorders. The region is expected to continue its strong market presence[1].

Asia-Pacific

The Asia-Pacific region is exhibiting the fastest growth in the antacids market, driven by increasing awareness about digestive health and changing lifestyles. This region presents significant opportunities for growth and expansion[1].

Consumer Preferences and Trends

Convenience and Flavor

Consumers are increasingly looking for antacids that are convenient to use and come in flavors that make them easier to consume. Chewable tablets with various flavors are gaining popularity, which bodes well for products like Antacid Xtra Strength Chew Tabs[1][3].

Natural Treatments

There is a growing interest in natural treatments, which could impact the sales of traditional antacids. However, the effectiveness and quick relief offered by products like Antacid Xtra Strength Chew Tabs are likely to maintain their market share[3].

Key Takeaways

  • Market Growth: The global antacids market is projected to grow at a CAGR of 4.8% from 2024 to 2032.
  • Consumer Preferences: Chewable and flavored tablets are in high demand due to their convenience and taste.
  • Distribution Channels: Retail pharmacies and online pharmacies are key channels for antacid sales.
  • Regional Growth: North America dominates the market, while the Asia-Pacific region is growing rapidly.
  • Product Positioning: Antacid Xtra Strength Chew Tabs are well-positioned due to their formulation, convenience, and flavor options.

FAQs

What is the projected market size of the global antacids market by 2032?

The global antacids market is estimated to achieve a market size of USD 10.9 billion by 2032[1].

Which drug class dominates the antacids market?

Proton Pump Inhibitors (PPIs) dominate the market due to their effectiveness in reducing stomach acid production[1].

What are the key distribution channels for antacids?

Retail pharmacies and online pharmacies are the key distribution channels for antacids[1][3].

Why are chewable tablets gaining popularity in the antacids market?

Chewable tablets are gaining popularity due to their convenience, precise dosing, and availability in various flavors, which enhance patient adherence to medication[1][4].

How is the Asia-Pacific region contributing to the growth of the antacids market?

The Asia-Pacific region is exhibiting the fastest growth in the antacids market, driven by increasing awareness about digestive health and changing lifestyles[1].

Sources

  1. Acumen Research and Consulting, "Antacids Market Size, Share, Trends | Forecast 2032"
  2. Target, "Extra Strength Antacid Chews - 90ct - Up&up"
  3. Biospace, "The Global Antacids Market Value to Surpass US$ 19 Bn by 2025"
  4. Maximize Market Research, "Antacids Market - Global Industry Analysis and Forecast (2024-2030)"
  5. Market Research Future, "Antacid Market Size, Growth Analysis, Trends, Report 2032"

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.